Inventiva IVA
NASDAQ IVA
$3.46 -0.23 (-6.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

Inventiva (IVA) Equity Income (2025)

Updated

Inventiva (IVA) posted Equity Income of -$407,415 for FY2025, compared with -$334,470 in FY2024.

Analysis

Inventiva (IVA) Equity Income (2025) Analysis & Trends

  • Business Quant data shows IVA's Equity Income at -$334,470 in FY2024 and -$2.17 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -10.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Inventiva 713.04 Mn 713.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -498,062.26
API Access

Inventiva Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=IVA&period=max&api_key=YOUR_API_KEY